Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07376486

Duodenal pulsENDO as an Early Treatment for Type 2 DM

Conditions: Diabete Mellitus, T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)

Sex: All

Ages: 18 Years – 60 Years

Healthy volunteers: No

Phase: NA

Enrollment: 40

Sponsor: Chinese University of Hong Kong

Location: Chinese University of Hong Kong Shatin

Summary

This study is designed to evaluate the efficacy and safety of endoscopic duodenal re-cellularization therapy using pulsed electric field in individuals with in patients with a recent diagnosis of type 2 diabetes mellitus (T2DM).

Eligibility Criteria

Inclusion Criteria: * Duration of T2DM \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07376486). StuddyBuddy aggregates publicly available trial information.